1-2 of 2
Philip C. Caron
Close
Sort by
Journal Articles

TP53 mutations identify high-risk events for peripheral T-cell lymphoma treated with CHOP-based chemotherapy

William T. Johnson, Nivetha Ganesan, Zachary D. Epstein-Peterson, Alison J. Moskowitz, Robert N. Stuver, Catherine R. Maccaro, Natasha Galasso, Tiffany Chang, Niloufer Khan, Umut Aypar, Natasha E. Lewis, Andrew D. Zelenetz, M. Lia Palomba, Matthew J. Matasar, Ariela Noy, Audrey M. Hamilton, Paul Hamlin, Philip C. Caron, David J. Straus, Andrew M. Intlekofer, Connie Lee Batlevi, Anita Kumar, Colette N. Owens, Craig S. Sauter, Lorenzo Falchi, Jennifer K. Lue, Santosha A. Vardhana, Gilles Salles, Ahmet Dogan, Nikolaus D. Schultz, Maria E. Arcila, Steven M. Horwitz
Journal: Blood Advances
Blood Adv (2023) 7 (17): 5172–5186.
https://doi.org/10.1182/bloodadvances.2023009953
Published: 2023
Includes: Supplemental data
Journal Articles

Retrospective characterization of nodal marginal zone lymphoma

Robert Stuver, Esther Drill, David Qualls, Michelle Okwali, Connie Lee Batlevi, Philip C. Caron, Ahmet Dogan, Zachary D. Epstein-Peterson, Lorenzo Falchi, Paul A. Hamlin, Steven M. Horwitz, Brandon S. Imber, Andrew M. Intlekofer, William T. Johnson, Niloufer Khan, Anita Kumar, Oscar B. Lahoud, Jennifer Kimberly Lue, Matthew J. Matasar, Alison J. Moskowitz, Ariela Noy, Colette N. Owens, M. Lia Palomba, Heiko Schöder, Santosha A. Vardhana, Joachim Yahalom, Andrew D. Zelenetz, Gilles Salles, David J. Straus
Journal: Blood Advances
Blood Adv (2023) 7 (17): 4838–4847.
https://doi.org/10.1182/bloodadvances.2022009587
Published: 2023
Includes: Supplemental data